<div id="readability-page-1"><p>In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Inotiv, with a price target of <span id="expert-recommendation-target">$5.00</span>.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Takkinen covers the Healthcare sector, focusing on stocks such as Sight Sciences, ClearPoint Neuro, and Artivion. According to TipRanks, Takkinen has an average return of <span>0.1%</span> and a 40.10% success rate on recommended stocks. </p> <p>Currently, the analyst consensus on Inotiv is a Moderate Buy with an average price target of $5.00.</p></div>

NOTV

<p>Lake Street analyst Frank Takkinen reiterated a Buy rating on Inotiv (NOTV) with a price target of $5.00. Takkinen, who covers the Healthcare sector, has an average return of 0.1% and a 40.10% success rate on recommended stocks. The analyst consensus on Inotiv is a Moderate Buy with an average price target of $5.00.</p>

Lake Street Keeps Their Buy Rating on Inotiv (NOTV)